triazoles has been researched along with Leishmaniasis, Cutaneous in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Andreazza Costa, MC; Borsodi, MPG; Cabral Abreu Grijó, B; Castro Ferreira, MM; Costa, AV; Lima, WP; Rodrigues Gazolla, PA; Rossi Bergmann, B; Teixeira, RR | 1 |
Almeida, ADC; Coimbra, ES; da Silva, AD; Glanzmann, N; Meinel, RS; Stroppa, PHF | 1 |
Antinarelli, LMR; Carmo, AML; Coimbra, ES; da Silva, AD; Gameiro, J; Stroppa, PHF | 1 |
Caridha, D; Grogl, M; Harris, M; Hickman, M; Hudson, TH; Lang, T; Lecoeur, H; Leed, S; Ngundam, F; O'Neil, M; Parriot, S; Read, L; Sciotti, R; Sena, J | 1 |
Benaim, G; Gelanew, T; Loucas, E; Paniz Mondolfi, AE; Perez Alvarez, AM; Polsky, B; Schoenian, G; Sordillo, EM; Stavropoulos, C | 1 |
Al-Abdely, HM; Graybill, JR; Loebenberg, D; Melby, PC | 1 |
6 other study(ies) available for triazoles and Leishmaniasis, Cutaneous
Article | Year |
---|---|
Eugenol derivatives with 1,2,3-triazole moieties: Oral treatment of cutaneous leishmaniasis and a quantitative structure-activity relationship model for their leishmanicidal activity.
Topics: Animals; Antiprotozoal Agents; Eugenol; Female; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine Antimoniate; Mice; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Triazoles | 2022 |
Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis.
Topics: Animals; Antiprotozoal Agents; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mitochondria; Phosphorylcholine; Reactive Oxygen Species; Triazoles | 2020 |
Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Cell Line; Erythrocytes; Humans; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages; Mice; Phosphorylcholine; Reactive Oxygen Species; Triazoles | 2017 |
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Female; Firefly Luciferin; Fluconazole; Genes, Reporter; High-Throughput Screening Assays; Leishmania major; Leishmaniasis, Cutaneous; Luciferases; Luminescent Measurements; Macrophages; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Ofloxacin; Optical Imaging; Organisms, Genetically Modified; Organometallic Compounds; Triazoles | 2017 |
Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazole.
Topics: Adult; Female; Humans; Leishmania infantum; Leishmaniasis, Cutaneous; Molecular Sequence Data; Polymerase Chain Reaction; Triazoles; Trypanocidal Agents | 2011 |
Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
Topics: Amphotericin B; Animals; Fluconazole; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liver; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Spleen; Time Factors; Triazoles; Trypanocidal Agents | 1999 |